ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $317,141 | -95.1% | 17,668 | -95.1% | 0.00% | -95.6% |
| Q1 2023 | $6,529,665 | +1121.9% | 357,986 | +1285.4% | 0.09% | +1025.0% |
| Q4 2022 | $534,371 | +131.1% | 25,840 | +46.2% | 0.01% | +166.7% |
| Q3 2022 | $231,231 | -93.9% | 17,672 | -88.3% | 0.00% | -96.0% |
| Q2 2022 | $3,814,000 | +722.0% | 150,496 | +1213.8% | 0.08% | +2400.0% |
| Q4 2021 | $464,000 | -52.1% | 11,455 | -70.8% | 0.00% | -90.6% |
| Q2 2020 | $969,000 | -74.6% | 39,167 | -85.7% | 0.03% | -78.7% |
| Q1 2020 | $3,811,000 | – | 274,570 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |